Skip to main content
4SC AG logo

4SC AG — Investor Relations & Filings

Ticker · VSC ISIN · DE000A3E5C40 LEI · 391200QOKN7LGVP0RQ86 F Manufacturing
Open in API
Filings indexed 719 across all filing types
Latest filing 2012-09-13 Regulatory Filings
Country DE Germany
Listing F VSC

About 4SC AG

https://www.4sc.com/

4SC AG is a biopharmaceutical company that formerly focused on the research and development of small-molecule drugs for cancer treatment. The company's strategy centered on addressing diseases with high unmet medical needs by developing innovative therapies that targeted epigenetic mechanisms of action. According to the company's official statements, it currently has no products under development and no operational business.

Recent filings

Filing Released Lang Actions
4SC's Anti-Cancer Drug Resminostat achieves Median Overall Survival of 8.0 Months in Second-Line Advanced Liver Cancer (HCC) Patients
Regulatory Filings Classification · 95% confidence The document is an 'Ad-hoc' announcement dated September 13, 2012, detailing clinical trial results (Median Overall Survival of 8.0 Months) for the anti-cancer drug Resminostat in HCC patients. It explicitly states that the data will be presented at the 2012 ILCA Conference on September 16, 2012. This format—a press release announcing significant, time-sensitive operational/clinical news, often mandated by regulations like § 15 WpHG (mentioned in the text)—is characteristic of an Earnings Release (ER) or a general Regulatory Filing (RNS). Since it is not a full financial report (10-K, IR) or a presentation/transcript, and it conveys key operational/clinical highlights immediately, it fits best as an Earnings Release (ER) which often includes operational updates alongside financial ones, or RNS as a general regulatory announcement. Given the focus on clinical trial data and future development plans, it functions as a major operational update, aligning closely with the purpose of an ER, even if not strictly quarterly earnings. However, since it is a specific, non-periodic announcement mandated by German securities law (§ 15 WpHG) about clinical progress, the most appropriate general category for such time-sensitive, non-standard reports is Regulatory Filings (RNS). If 'ER' is interpreted strictly as quarterly financial results, RNS is the better fit for this specific clinical update announcement.
2012-09-13 English
Q2 Report 2012
Interim / Quarterly Report Classification · 100% confidence The document is titled 'CONSOLIDATED HALF-YEAR FINANCIAL REPORT' and covers the period ending 30 June 2012. It contains detailed financial statements (Consolidated Statement of Comprehensive Income, Statement of Financial Position, Cash Flows, etc.) and an 'Interim Group Management Report'. Since it is a comprehensive financial report for a period shorter than a full fiscal year (half-year) and contains substantive financial data, it is classified as an Interim/Quarterly Report. H1 2012
2012-08-22 English
Press Release: 4SC's successful start to the year continues in Q2 of 2012
Earnings Release Classification · 100% confidence The document is titled 'Press Release' and announces the financial results for the 'second quarter and the first six months of 2012'. It provides key financial figures (revenue, operating loss, cash position) and operational highlights for the period. This structure strongly indicates an initial announcement of periodic financial results, which aligns with the definition of an Earnings Release (ER). Although it mentions the 'complete quarterly report will be available for download,' the document itself is the press release summarizing those results, not the full report (which would be classified as IR). It is not a transcript (CT), a full annual report (10-K), or a general regulatory filing (RNS), as it is specifically focused on periodic financial performance highlights. H1 2012
2012-08-09 English
Press Release: 4SC AG further strengthens Supervisory Board with experienced managers from the pharmaceutical industry
Board/Management Information Classification · 100% confidence The document is a press release dated August 6, 2012, announcing changes to the Supervisory Board following the Annual General Meeting (AGM) held on the same day. It explicitly mentions that Dr Irina Antonijevic and Mr Klaus Kühn were elected to the Supervisory Board 'In a by-election at today's Annual General Meeting of 4SC AG'. Furthermore, it lists several resolutions approved at the AGM, such as the approval of the remuneration system and capital structure changes. Since the core content is about the proceedings and outcomes of the Annual General Meeting, the most appropriate classification is AGM Information (AGM-R). Although it mentions management changes (MANG) and remuneration approval (DEF 14A), the context is strictly tied to the AGM event itself.
2012-08-06 English
Announcement: 4SC to host conference call on 9 August 2012 to present Q2 2012 results
Report Publication Announcement Classification · 99% confidence The document is a short announcement (4188 characters) dated August 2, 2012, stating that 4SC AG "will announce results of the 4SC Group for the second quarter of 2012 and publish the Company's half year report 2012 on 9 August 2012." It further states that the Management Board "will host a conference call at 3pm CEST... to inform about the consolidated financial statements in the reporting period." This document is not the actual Q2/Half Year Report (IR) or the Earnings Release (ER), but rather an announcement about the upcoming publication of those reports and the associated conference call. Since it announces the publication of reports and provides details about an upcoming event (the call), it fits best under the category for announcing the release of reports, which is Report Publication Announcement (RPA). It is not a full transcript (CT) or the report itself (IR).
2012-08-02 English
4 SC AG: Veroffentlichung gema 26a Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a short announcement dated July 31, 2012, titled 'Veröffentlichung der Gesamtzahl der Stimmrechte' (Publication of the Total Number of Voting Rights) according to German regulation (§ 26a WpHG). It explicitly states the total number of voting rights (50,371,814) as of the end of July 2012. This content directly relates to the official count of shares eligible to vote, which falls under the category of voting rights announcements, specifically the total count rather than the results of a vote (DVA). Since there is no specific code for 'Total Voting Rights Announcement', and it is a regulatory disclosure about share structure/rights, it is best classified as a general Regulatory Filing (RNS) or potentially related to DVA if interpreted broadly. However, DVA is defined as 'Official results from shareholder votes'. Given the nature of announcing the total number of rights, and its regulatory origin, RNS is the most appropriate fallback for a specific regulatory disclosure not covered elsewhere. The document is very short (1237 chars) and is a direct announcement, not a summary of a larger report.
2012-07-31 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.